is glp 1 or tirzepatide better Semaglutide vs for Weight Loss Your Off-Brand GLP-1 Is Dirtier

Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes

Dehydration and kidney injury Repeated vomiting or diarrhea can cause volume depletion

Potential Benefits People Report Although not confirmed in large clinical trials, some individuals exploring microdosing GLP-1 report: Fewer gastrointestinal symptoms Subtle appetite changes Easier re-initiation after treatment pauses These experiences vary by individual and should not be interpreted as guaranteed outcomes

Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial